DSpace
 

Researchspace >
General science, engineering & technology >
General science, engineering & technology >
General science, engineering & technology >

Please use this identifier to cite or link to this item: http://hdl.handle.net/10204/5761

Title: Effects of protein binding on the biodistribution of PEGylated PLGA nanoparticles post oral administration
Authors: Semete, B
Booysen, L
Kalombo, L
Ramalapa, B
Hayeshi, R
Swai, HS
Keywords: Nanoparticles
Nanotechnology
Polymeric surfactants
Protein binding
PEGylated PLGA nanoparticles
Issue Date: Mar-2012
Publisher: Elsevier
Citation: Semete, B, Booysen, L, Kalombo, L, Ramalapa, B, Hayeshi, R and Swai, HS. 2012. Effects of protein binding on the biodistribution of PEGylated PLGA nanoparticles post oral administration. International Journal of Pharmaceutics, vol. 424(1-2), pp 115-120
Series/Report no.: Workflow;8762
Abstract: The surface of nanoparticles is often functionalised with polymeric surfactants, in order to increase systemic circulation time. This has been investigated mainly for intravenously administered nanoparticles. This study aims to elucidate the effect of surface coating with various concentrations of polymeric surfactants (PEG and Pluronics F127) on the in vitro protein binding as well as the tissue biodistribution, post oral administration, of PLGA nanoparticles. The in vitro protein binding varied depending on the polymeric surfactant used. However, in vivo, 1% PEG and 1% Pluronics F127 coated particles presented similar biodistribution profiles in various tissues over seven days. Furthermore, the percentage of PEG and Pluronics coated particles detected in plasma was higher than that of uncoated PLGA particles, indicating that systemic circulation time can also be increased with oral formulations. The difference in the in vitro protein binding as a result of the different poloxamers used versus similar in vivo profiles of these particles indicates that in vitro observations for nanoparticles cannot represent or be correlated to the in vivo behaviour of the nanoparticles. Our results therefore suggest that more studies have to be conducted for oral formulations to give a better understanding of the kinetics of the particles.
Description: Copyright: 2011 Elsevier. This is the post-print version of the work. The definitive version is published in the International Journal of Pharmaceutics, vol. 424(1-2), pp 115-120
URI: http://www.sciencedirect.com/science/article/pii/S0378517311011732
http://hdl.handle.net/10204/5761
ISSN: 0378-5173
Appears in Collections:Nanotechnology
General science, engineering & technology

Files in This Item:

File Description SizeFormat
Hayeshi_2012.pdf673.2 kBAdobe PDFView/Open
View Statistics

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2010  Duraspace - Feedback